非创伤性2区TEVAR中左锁骨下动脉血运重建:颈锁骨下转流/转位与腔内技术的围手术期结局
基于VQI前瞻性数据,纳入837例非创伤性2区TEVAR并同期行左锁骨下动脉血运重建患者,比较颈锁骨下转流/转位(CS-BpTp)与腔内技术(ETs)的围手术期结局。结果显示两组30天死亡率(3% vs 3%)、TIA/卒中(5.5% vs 5%)及脊髓缺血(3% vs 3%)均无显著差异。
要点
- 非创伤性2区TEVAR中,CS-BpTp与ETs的30天死亡、TIA/卒中、脊髓缺血率相似。
- 多因素回归未识别任一血运重建方式为死亡或TIA/卒中的独立预测因子。
- 两种技术围手术期安全有效,但ETs长期耐久性仍需前瞻性研究。
核心结论
- 在VQI中,非创伤性2区TEVAR期间采用CS-BpTp或ETs行左锁骨下动脉血运重建均安全有效。
- 两种技术在选定患者中围手术期结局相似,死亡率和主要神经并发症发生率低。
研究设计与样本
- 基于血管外科学会血管质量倡议(VQI)前瞻性收集数据(2013-2018年)的回顾性队列研究。
- 纳入837例接受非创伤性2区TEVAR并同期行左锁骨下动脉血运重建的患者。
- 主要暴露为血运重建技术:CS-BpTp或任何ETs;若多次TEVAR,取首次涉及2区的病例进行分析。
主要发现
- 最常见的病理为夹层326例(45%)和动脉瘤248例(34%)。
- 721例(86%)接受CS-BpTp,116例(16%)接受ETs;ETs包括23例烟囱支架、3例扇贝支架、15例开窗支架和75例分支支架。
- 两组死亡率均为3%(P=0.67);TIA/卒中率分别为5.5%和5%(P=0.78);全队列脊髓缺血率为3%,组间无显著差异(P=1)。
- 多因素逻辑回归未能识别CS-BpTp或ETs为死亡或TIA/卒中的独立预测因子。
临床怎么用
- 对于非创伤性2区TEVAR需左锁骨下动脉血运重建的患者,CS-BpTp和ETs均可作为可选方案。
- 选择术式时可结合患者解剖条件和术者经验,两者围手术期死亡和主要神经并发症风险相似。
- 需关注ETs的长期耐久性,术后应规律随访。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of our study is to examine the perioperative outcomes of carotid-subclavian bypass or transposition (CS-BpTp) versus endovascular techniques (ETs) for left subclavian artery (LSA) revascularization during nontraumatic zone 2 thoracic endovascular aortic repair (TEVAR). METHODS: We used prospectively collected data from the Society for Vascular Surgery Vascular Quality Initiative (VQI) to identify patients who had undergone TEVAR at participating centers (2013-2018). Patients were eligible for inclusion if they had undergone nontraumatic zone 2 TEVAR and concomitant LSA revascularization. Our main exposure of interest was LSA revascularization technique, CS-BpTp, or any ET. If a patient underwent multiple TEVAR procedures during the study period, the first case involving zone 2 was used for analysis. Preoperative patient characteristics were reviewed between treatment groups. The primary outcomes were mortality, transient ischemic attack (TIA)/stroke, and spinal cord ischemia (SCI). All outcomes were assessed up to 30 days postoperatively. RESULTS: A total of 837 patients were included in the study. The pathologies most frequently treated were aneurysm in 248 (34%) and dissection in 326 (45%). Overall, 721 subjects (86%) underwent CS-BpTp while 116 subjects (16%) underwent ETs. The latter included the following techniques: 23 chimney grafts, 3 scallops, 15 fenestrated grafts, and 75 branched grafts. Mortality was equal at 3% for both groups (P = 0.67). The rate of TIA/stroke was not significantly different in both groups (5.5% vs. 5%, P = 0.78). Similarly, the rate of SCI was 3% in the entire cohort without significant differences seen between treatment groups (P = 1). Multivariate logistic regression could not identify either CS-BpTp or ETs as independent predictors for death or TIA/stroke. CONCLUSIONS: Within VQI, LSA revascularization during nontraumatic zone 2 TEVAR is safely and effectively achieved with either CS-BpTp or ETs across all nontraumatic thoracic aortic diseases. These techniques appear to be associated with similar perioperative outcomes in selected patients with low rates of mortality and major neurologic morbidity. Although no differences were seen in the proportion of early type I or III endoleaks, further prospective studies are warranted to elucidate the long-term durability of ETs compared with CS-BpTp.
引用
- D'Oria M, Kärkkäinen JM, Tenorio ER, et al. Perioperative Outcomes of Carotid-Subclavian Bypass or Transposition versus Endovascular Techniques for Left Subclavian Artery Revascularization during Nontraumatic Zone 2 Thoracic Endovascular Aortic Repair in the Vascular Quality Initiative. Ann Vasc Surg. 2020. PMID: 32505683. doi:10.1016/j.avsg.2020.05.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。